Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group

BACKGROUND: Historically, a priori power and sample size calculations have not been routinely performed cost-effectiveness analyses (CEA), partly because the absence of published cost and effectiveness correlation and variance data, which are essential for power and sample size calculations. Importa...

Descripción completa

Detalles Bibliográficos
Autores principales: Everest, Louis, Chen, Bingshu E., Hay, Annette E., Cheung, Matthew C., Chan, Kelvin K. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398980/
https://www.ncbi.nlm.nih.gov/pubmed/37537545
http://dx.doi.org/10.1186/s12874-023-01956-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398980/
https://www.ncbi.nlm.nih.gov/pubmed/37537545
http://dx.doi.org/10.1186/s12874-023-01956-y

Ejemplares similares